Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease Janssen-Heininger YM; Aesif SW; van der Velden J; Guala AS; Reiss JN; Roberson EC; Budd RC; Reynaert NL; Anathy VAnn N Y Acad Sci 2010[Aug]; 1203 (ä): 23-8Tissue fibrosis is believed to be a manifestation of dysregulated repair following injury, in association with impaired reepithelialization, and aberrant myofibroblast activation and proliferation. Numerous pathways have been linked to the pathogenesis of fibrotic lung disease, including the death receptor Fas, which contributes to apoptosis of lung epithelial cells. A redox imbalance also has been implicated in disease pathogenesis, although mechanistic details whereby oxidative changes intersect with profibrotic signaling pathways remain elusive. Oxidation of cysteines in proteins, such as S-glutathionylation (PSSG), is known to act as a regulatory event that affects protein function. This manuscript will discuss evidence that S-glutathionylation regulates death receptor induced apoptosis, and the potential implications for cysteine oxidations in the pathogenesis of in fibrotic lung disease.|Animals[MESH]|Apoptosis/*physiology[MESH]|Catalytic Domain/physiology[MESH]|Cysteine/chemistry/*metabolism[MESH]|Fibrosis[MESH]|Glutathione/chemistry/metabolism[MESH]|Humans[MESH]|Lung Diseases/*metabolism/*pathology[MESH]|Oxidation-Reduction[MESH]|Signal Transduction/physiology[MESH] |